Back to Results
First PageMeta Content
Medicine / Biology / Guillain–Barré syndrome / Syndromes / Intravenous immunoglobulin / Polyradiculoneuropathy / Acute motor axonal neuropathy / Barre / Peripheral neuropathy / Neurological disorders / Health / Autoimmune diseases


Practice parameter: Immunotherapy for Guillain−Barré syndrome: Report of the Quality Standards Subcommittee of the American Academy of Neurology
Add to Reading List

Open Document

File Size: 163,15 KB

Share Result on Facebook

City

Wynnewood / San Francisco / St. Paul / Paris / Oxford / Rochester / Baltimore / Washington / DC / Atlanta / London / /

Company

Novartis / California Pacific Medical Center / AAN Enterprises Inc. / Acknowledgment The GBS Practice Parameter Group / Abd-Allah SA / Allos / MEDLINE / HP / Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group / Guillain-Barré Syndrome Steroid Trial Group / French Cooperative Group / Bayer Corporation / /

Country

Netherlands / Canada / United Kingdom / China / India / United States / /

Currency

USD / /

Facility

Fort Wayne / The University of Alabama / University of Kansas Medical Center / Cochrane library / Mayo Clinic / Fort Wayne Neurological Center / /

IndustryTerm

therapy for pediatric Guillain-Barré syndrome / online version / human blood product / treatment of Guillain-Barré syndrome / treatment for GuillainBarre syndrome / treatment of Guillain-Barre syndrome / treatment for Guillain-Barré syndrome / practice parameter / search results / /

MedicalCondition

hypocalcemia / Barré syndrome / acute Guillain-Barré syndrome / intrathecal infection / persistent fatigue / infusion site erythema / Ashwal S. Guillain-Barré syndrome / acute flaccid paralysis / severe disease / pneumonia / acute paralytic disease / Inanainen M. Guillain-Barré syndrome / respiratory failure / Guillain-Barré syndrome / Guillain-Barre syndrome / septicemia / vomiting / renal failure / DF / acute inflammatory polyradiculoneuropathy / Guillain−Barré syndrome / meningism / acute polyneuropathy / Polyradiculoneuritis / fatigue / pediatric Guillain-Barré syndrome / GuillainBarre syndrome / MS / Fisher’s syndrome / hypotension / hypertension / idiopathic polyneuritis / disease / autonomic and pulmonary function / atelectasis / pain / myocardial infarction / acute inflammatory polyneuropathy / immune-mediated polyneuropathies / Campylobacter-associated Guillain-Barré syndrome / thrombosis / childhood Guillain-Barre syndrome / /

MedicalTreatment

Immunotherapy / plasma exchange / mechanical ventilation / plasma exchanges / Plasmapheresis / /

Organization

Fort Wayne Neurological Center / Quality Standards Subcommittee / American Academy of Neurology / University of Kansas Medical Center / Kansas City / Department of Neuroimmunology / University of Alabama / Birmingham / School of Medicine / American Academy of Neurology R.A.C. Hughes / Division of Neurology / United States Department of Agriculture / AAN Quality Standards Subcommittee / Department of Neurology / London Health Sciences Center / Emory University School of Medicine / Department of Physical Medicine and Rehabilitation / Johns Hopkins University School of Medicine / /

Person

Assessment / Allan Ropper / A.F. Hahn / Ann Neurol / J. Sladky / R.G. Miller / E. Benson / D. Cornblath / Van Koningsveld / J. Meythaler / J. Stevens / R. Barohn / D.R. Cornblath / J.M. Meythaler / E.F.M. Wijdicks / A. Hahn / J.C. Stevens / J.T. Sladky / R.A.C. Hughes / /

Position

Dobyns WB / Konkol RJ / physician / McQuillen MP / King / Fisher / /

Product

methylprednisolone / ACTH / prednisolone / prednisone / /

ProvinceOrState

Minnesota / Alabama / Prince Edward Island / California / Georgia / Kansas / Maryland / Pennsylvania / /

Region

northern China / Scandinavia / south east England / /

URL

http /

SocialTag